Prime Medicine, Inc.·4

Apr 4, 8:22 PM ET

LEE ANN L. 4

4 · Prime Medicine, Inc. · Filed Apr 4, 2023

Insider Transaction Report

Form 4
Period: 2023-03-31
LEE ANN L.
Chief Technical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-31+180,995180,995 total
    Exercise: $12.30Exp: 2033-03-31Common Stock (180,995 underlying)
Footnotes (1)
  • [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 31, 2023, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file
  • 4
    wf-form4_168065413914963.xmlPrimary

    FORM 4